Pulling back from their 52-week highs, these top-rated stocks are viable options for long-term positions in the portfolio.
The average of price targets set by Wall Street analysts indicates a potential upside of 26.8% in Celestica (CLS). While the effectiveness of this highly sought-after metric is questionable, the posit

Celestica: Fueled By Relentless Catalysts

04:24am, Tuesday, 25'th Feb 2025
Celestica's strong Q4 performance and robust FY2025 guidance, driven by AI tailwinds and data center spending, support a "Strong buy" rating. The stock's valuation is attractive, with a DCF model indi
Subscribers to Schaeffer's Weekend Trader options recommendation service received this CLS commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry an
Trump's tariffs cause short-term volatility, but long-term market impact is minimal; earnings remain the key focus for investors. The three countries in questions are Canada, China, and Mexico. This b
Here is how Celestica (CLS) and Anterix (ATEX) have performed compared to their sector so far this year.
Celestica (CLS) possesses solid growth attributes, which could help it handily outperform the market.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Five high-flying non-US. tech stocks have strong revenue and earnings growth potential for 2025.
CLS is well poised for sustained growth backed by robust infrastructure investments, solid technology know-how and wide industry experience.
Invest in stocks of EAT, BFST, AZEK, CLS and BSX to tap their high efficiency levels.
ENS, PCRX, CLS and ENVA are four stocks with explosive relative price strength.
Celestica's stock rating is adjusted from a strong buy to a buy due to a rapid share price increase and coming off seasonal strength. The CCS segment, driven by AI CapEX, is growing fast and dominatin
- BCVA and CST Data from Sub-Group Analyses Provide Key Insights for Planned CLS-AX Phase 3 Trial Design - - BCVA and CST Data from Sub-Group Analyses Provide Key Insights for Planned CLS-AX Phase 3 T

Celestica: Room For Margin And Multiple Expansion

07:45am, Wednesday, 05'th Feb 2025
An SA Quant top 10 stock for 2025. Celestica's integration into the data center/AI supply chain is fueling its growth and transforming its business model with own R&D, innovation and design potencial.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE